Acid Reflux Research Today is a free monthly online journal that collates and summarizes the latest research about Acid Reflux, including details on diet, gerd (gastro-esophageal reflux disease), treatment, symptoms.

Volume 2 (2005), Issue 6 (June)

1. Functional problems following esophageal surgery.
   Surg Clin North Am, 85(3): 525-38. [Abstract] [Full-text]
2. Endoscopic therapies for gastroesophageal reflux disease.
   Surg Clin North Am, 85(3): 465-81, viii. [Abstract] [Full-text]
3. Quality of life measurement in the management of gastroesophageal reflux disease.
   Surg Clin North Am, 85(3): 453-63. [Abstract] [Full-text]
4. Partial versus complete fundoplication: is there a correct answer?
   Surg Clin North Am, 85(3): 399-410. [Abstract] [Full-text]
5. Gastric fullness, physical activity, and proximal extent of gastroesophageal reflux.
   Am J Gastroenterol, 100(6): 1251-6. [Abstract] [Full-text]
6. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.
   Am J Gastroenterol, 100(6): 1243-50. [Abstract] [Full-text]
7. Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey.
   Am J Gastroenterol, 100(6): 1237-42. [Abstract] [Full-text]
8. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis.
   Am J Gastroenterol, 100(6): 1226-32. [Abstract] [Full-text]
9. Effect of CYP2C19 polymorphism on the safety and efficacy of omeprazole in Japanese patients with recurrent reflux oesophagitis.
   Aliment Pharmacol Ther, 21(11): 1331-9. [Abstract] [Full-text]
10. Empirical treatment for the management of patients presenting with uninvestigated reflux symptoms: a prospective study in an Asian primary care population.
    Aliment Pharmacol Ther, 21(11): 1313-20. [Abstract] [Full-text]
11. Systematic review: the efficacy of intermittent and on-demand therapy with histamine H2-receptor antagonists or proton pump inhibitors for gastro-oesophageal reflux disease patients.
    Aliment Pharmacol Ther, 21(11): 1299-312. [Abstract] [Full-text]
12. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther, 21: 10-8. [Abstract] [Full-text]
13. Efficacy of famotidine and omeprazole in healing symptoms of non-erosive gastro-oesophageal reflux disease: randomized-controlled study of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther, 21: 2-9. [Abstract] [Full-text]
14. Delayed gastric emptying in gastroesophageal reflux disease: the role of malrotation.
    Pediatr Surg Int, 21(6): 423-7. [Abstract] [Full-text]
15. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old.
    Br J Clin Pharmacol, 59(6): 725-9. [Abstract] [Full-text]
16. Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia.
    Aliment Pharmacol Ther, 21(12): 1483-90. [Abstract] [Full-text]
17. Postprandial oesophageal integrated acidity is a reliable predictor of gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther, 21(12): 1475-82. [Abstract] [Full-text]
18. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
    Aliment Pharmacol Ther, 21(12): 1467-74. [Abstract] [Full-text]
19. Is proton pump inhibitor testing an effective approach to diagnose gastroesophageal reflux disease in patients with noncardiac chest pain?: a meta-analysis.
    Arch Intern Med, 165(11): 1222-8. [Abstract] [Full-text]
20. Changing prevalence of gastroesophageal reflux with changing time: longitudinal study in an Asian population.
    J Gastroenterol Hepatol, 20(7): 995-1001. [Abstract] [Full-text]
21. The mechanical basis of impaired esophageal emptying postfundoplication.
    Am J Physiol Gastrointest Liver Physiol, 289(1): G21-35. [Abstract] [Full-text]
22. Randomized double-blind trial of laparoscopic Nissen fundoplication versus anterior partial fundoplication.
    Br J Surg, 92(7): 819-23. [Abstract] [Full-text]
23. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Dig Liver Dis, 37(7): 485-90. [Abstract] [Full-text]
24. Does this patient have oesophageal motility abnormality or pathological acid reflux?
    Dig Liver Dis, 37(7): 475-84. [Abstract] [Full-text]
25. Management of reflux disease in clinical praxis in hungary.
    Z Gastroenterol, 43(6): 575-80. [Abstract] [Full-text]
26. Dyspepsia and GERD: breaking the rules.
    Am J Gastroenterol, 100(7): 1489-90. [Abstract] [Full-text]
27. Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community.
    Am J Gastroenterol, 100(7): 1459-65. [Abstract] [Full-text]
28. Does gastroesophageal reflux cause apnea in preterm infants?
    Biol Neonate, 87(4): 254-61. [Abstract] [Full-text]

© 2004-2008 Acid Reflux Research Today. All Rights Reserved.